Bifogade filer
Invitation to Senzime's investor event
Kurs
-2,10%
Likviditet
0,08 MSEK
Prenumeration
Kalender
| Est. tid* | ||
| 2025-11-07 | 08:30 | Kvartalsrapport 2025-Q3 |
| 2025-08-27 | 08:30 | Kvartalsrapport 2025-Q2 |
| 2025-05-20 | N/A | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2025-05-19 | N/A | Årsstämma |
| 2025-04-22 | - | Kvartalsrapport 2025-Q1 |
| 2025-02-17 | - | Bokslutskommuniké 2024 |
| 2024-11-06 | - | Kvartalsrapport 2024-Q3 |
| 2024-10-23 | - | Extra Bolagsstämma 2024 |
| 2024-08-26 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-17 | - | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2024-05-16 | - | Årsstämma |
| 2024-05-07 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-15 | - | Bokslutskommuniké 2023 |
| 2023-11-28 | - | Extra Bolagsstämma 2023 |
| 2023-10-26 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-24 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-17 | - | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2023-05-16 | - | Årsstämma |
| 2023-04-28 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-20 | - | Bokslutskommuniké 2022 |
| 2023-02-16 | - | Extra Bolagsstämma 2022 |
| 2022-11-10 | - | Kvartalsrapport 2022-Q3 |
| 2022-07-15 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-19 | - | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2022-05-18 | - | Årsstämma |
| 2022-05-05 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-11-12 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-27 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-12 | - | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2021-05-11 | - | Årsstämma |
| 2021-05-06 | - | Kvartalsrapport 2021-Q1 |
| 2021-03-05 | - | Extra Bolagsstämma 2021 |
| 2021-02-26 | - | Bokslutskommuniké 2020 |
| 2020-11-06 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-21 | - | Kvartalsrapport 2020-Q2 |
| 2020-07-02 | - | Extra Bolagsstämma 2020 |
| 2020-05-15 | - | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2020-05-14 | - | Årsstämma |
| 2020-05-08 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-14 | - | Bokslutskommuniké 2019 |
| 2019-11-08 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-22 | - | Kvartalsrapport 2019-Q2 |
| 2019-08-21 | - | Extra Bolagsstämma 2019 |
| 2019-05-09 | - | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2019-05-08 | - | Årsstämma |
| 2019-05-08 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-15 | - | Bokslutskommuniké 2018 |
| 2018-11-08 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-22 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-09 | - | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2018-05-08 | - | Årsstämma |
| 2018-05-08 | - | Kvartalsrapport 2018-Q1 |
| 2018-03-05 | - | Extra Bolagsstämma 2018 |
| 2018-02-16 | - | Bokslutskommuniké 2017 |
| 2017-11-28 | - | Kvartalsrapport 2017-Q3 |
| 2017-09-15 | - | Extra Bolagsstämma 2017 |
| 2017-08-31 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-23 | - | Årsstämma |
| 2017-05-23 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-16 | - | Bokslutskommuniké 2016 |
| 2016-11-22 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-31 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-17 | - | Extra Bolagsstämma 2016 |
| 2016-04-28 | - | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2016-04-27 | - | Årsstämma |
| 2016-04-27 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-18 | - | Bokslutskommuniké 2015 |
| 2015-11-24 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-26 | - | Kvartalsrapport 2015-Q2 |
| 2015-05-20 | - | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2015-05-19 | - | Årsstämma |
| 2015-05-19 | - | Kvartalsrapport 2015-Q1 |
| 2015-02-25 | - | Bokslutskommuniké 2014 |
| 2014-11-27 | - | Kvartalsrapport 2014-Q3 |
| 2014-11-21 | - | Extra Bolagsstämma 2014 |
| 2014-08-21 | - | Kvartalsrapport 2014-Q2 |
| 2014-05-15 | - | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2014-05-14 | - | Årsstämma |
| 2014-05-14 | - | Kvartalsrapport 2014-Q1 |
| 2014-02-24 | - | Bokslutskommuniké 2013 |
| 2013-11-27 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-20 | - | Kvartalsrapport 2013-Q2 |
| 2013-05-16 | - | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2013-05-15 | - | Årsstämma |
| 2013-05-15 | - | Kvartalsrapport 2013-Q1 |
| 2013-02-28 | - | Bokslutskommuniké 2012 |
| 2013-01-08 | - | Extra Bolagsstämma 2013 |
| 2012-11-21 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-21 | - | Kvartalsrapport 2012-Q2 |
| 2012-05-24 | - | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2012-05-23 | - | Årsstämma |
| 2012-05-23 | - | Kvartalsrapport 2012-Q1 |
| 2012-02-22 | - | Bokslutskommuniké 2011 |
| 2011-11-23 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-23 | - | Kvartalsrapport 2011-Q2 |
| 2011-05-27 | - | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2011-05-26 | - | Årsstämma |
| 2011-05-26 | - | Kvartalsrapport 2011-Q1 |
| 2011-02-16 | - | Bokslutskommuniké 2010 |
| 2010-11-24 | - | Kvartalsrapport 2010-Q3 |
| 2010-05-28 | - | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2010-05-27 | - | Kvartalsrapport 2010-Q1 |
| 2009-11-25 | - | Kvartalsrapport 2009-Q3 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Small Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Senzime AB (publ) invites investors, financial analysts and media to a digital investor event on November 15, 2022, in the afternoon.
The purpose is to give an update of the strategy following the acquisition of Respiratory Motion, describe the market opportunities following the upcoming clinical guidelines in the US and Europe that support Senzime’s solutions, and provide long-term financial targets.
Presentations will be held by:
- Pia Renaudin, CEO of Senzime
- Sorin J. Brull, Professor, board member of Senzime AB and the innovator of TetraGraph
- Kay Krüger, business manager of the recently acquired ExSpiron business who will present the latest updates on market development in Europe and the US
Presentations will be held in English and followed by a Q&A session.
Date and time
Tuesday November 15, 2022, at 13:00-15:00 CET.
More information and a link to the event will be shared in the beginning of November.
For further information, please contact:
Pia Renaudin, CEO of Senzime AB
Phone: +46 (0) 70-813 34 17, email: pia.renaudin@senzime.com
About Senzime
Senzime is a Swedish medical device company that develops, manufactures, and markets CE- and FDA-cleared patient monitoring systems. Senzime’s employees worldwide are committed to the vision of a world without anesthesia- and respiratory-related complications. The company markets an innovative portfolio of solutions, including the TetraGraph® and ExSpiron® 2Xi for real-time monitoring of neuromuscular and respiratory functions, typically under and after surgery. The goal is to help eliminate in-hospital complications, and radically reduce health care costs related to surgical and high acuity procedures.
Senzime targets a market opportunity valued more than SEK 40 billion per year, and operates with sales teams in the world’s leading markets. The company’s shares are listed on Nasdaq Stockholm Main Market (SEZI). More information is available at senzime.com.